UBS thinks investors should buy shares of Keurig Dr Pepper at these levels.
Analyst Peter Grom said Keurig Dr Pepper is trading at a valuation below its historical averages and relative to peers, presenting a buying opportunity to investors.
"At a time when earnings growth is set to decelerate across many Beverage peers, this shift in relative earnings momentum should narrow the valuation gap closer to historical averages," Grom said.
The analyst added Keurig Dr Pepper's coffee segment could potentially underpin revenue expansion, while also benefiting from stronger brand partnerships overall.
KDP YTD mountain Keurig Dr Pepper stock has dipped more than 6% from the start of 2023.
Persons:
Dr Pepper, Peter Grom, FactSet, Grom, Pepper, — CNBC's Michael Bloom
Organizations:
UBS, Beverage, US